Accreditation Council for Genetic Counseling Appoints New ... ( MCLEAN ...) bio-medicine.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bio-medicine.org Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who have symptoms consistent with, or a diagnosis of, cerebral palsy (CP) with no evidence of brain injury.
CP is a group of disorders that affect a person s ability to move and maintain balance and posture. Many of the common symptoms of CP are similar to other neurotransmitter disorders, such as Aromatic L-amino Acid Decarboxylase (AADC) deficiency, resulting in potential misdiagnosis. The program, PTC Pinpoint Direct™-CP Spectrum, is an innovative, genetic testing program which includes expert genetic counseling at no charge for eligible patients.
Global Genomic Medicine Market Trends and Vendors Analysis after Covid-19 Pandemic Opportunities Scenario Highlighting Major Drivers & Trends 2021-2028 – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Global Genomic Medicine Market
Genomic medicine market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to grow at a CAGR of 9.70% in the above-mentioned forecast period. Increasing scientific research on genomic medicine is expected to create new opportunity for the market.
Market study of Genomic Medicine business report considers a market attractiveness analysis, where each segment is benchmarked based on its market size, growth rate, and general attractiveness. This research report helps to understand the various drivers and restraints impacting the market during the forecast period. The report has been formed by using information from trustworthy sources such as journals, websites, and annual reports of the companies, white papers, and mergers. All of this collected data is then checked and validated by the market experts for the readers and end users. The global Genomic Medicine report has ap